Facing the loss of his beloved rescue dog, a tech entrepreneur enlisted AI and ChatGPT to co-develop an experimental cancer vaccine.

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

When Rosie, an eight-year-old rescue dog, was diagnosed with aggressive cancer, her owner feared the worst. Surgery and chemotherapy slowed the diseas.

Paul Conyngham, a tech entrepreneur from Australia, claimed that he used artificial intelligence (AI) and ChatGPT to create a personalised cancer vaccine for his rescue dog, Rosie ...

A Sydney data engineer has developed the world's first personalised mRNA cancer vaccine for a dog using AI tools like ChatGPT ...

When veterinary chemotherapy failed to stop Rosie – his rescue dog – from succumbing to aggressive mast cell cancer, Paul ...

Paul Conyngham used a "chatbot to brainstorm possible cures" for his dog, Rosie, who was diagnosed with a deadly mast cell ...

An AI-designed mRNA vaccine has successfully treated a Sydney dog with cancer, shrinking her tumor by half and offering hope ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Riddled with cancer, Rosie the rescue dog had only months to live, until her dogged owner collared a chatbot to collaborate with elite medical scientists in the quest for a cure.

Enrollment has been completed for a phase 2a randomized clinical trial evaluating the investigational microbiome therapeutic EBX-102-02 in patients undergoing allogeneic hematopoietic stem cell ...

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer. New Study Reveals How Bladder Cancer “Hijacks” the Immune System — Opening Door to ...